Gene: PRKAR2A
Official Full Name: protein kinase cAMP-dependent type II regulatory subunit alphaprovided by HGNC
Gene Summary: cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. It may interact with various A-kinase anchoring proteins and determine the subcellular localization of cAMP-dependent protein kinase. This subunit has been shown to regulate protein transport from endosomes to the Golgi apparatus and further to the endoplasmic reticulum (ER). [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02850 | PRKAR2A Knockout cell line (HeLa) | Human | PRKAR2A | 1:3~1:6 | Negative | Online Inquiry |
KO02851 | PRKAR2A Knockout cell line (HCT 116) | Human | PRKAR2A | 1:2~1:4 | Negative | Online Inquiry |
KO02852 | PRKAR2A Knockout cell line (HEK293) | Human | PRKAR2A | 1:3~1:6 | Negative | Online Inquiry |
KO02853 | PRKAR2A Knockout cell line (A549) | Human | PRKAR2A | 1:3~1:4 | Negative | Online Inquiry |
PRKAR2A Gene Knockout Cell Lines are meticulously designed biological tools engineered to facilitate the study of the protein kinase A (PKA) signaling pathway by disrupting the PRKAR2A gene. This gene encodes the regulatory subunit type II-alpha of PKA, which plays a crucial role in various fundamental cellular processes, including growth, proliferation, and apoptosis. By creating knockout models, researchers can investigate the downstream effects of altered PKA signaling, thus providing insights into its involvement in disease states such as cancer and endocrine disorders.
The mechanism of action for these cell lines involves precise gene editing techniques, such as CRISPR-Cas9 or homologous recombination, to induce disruptions in the PRKAR2A gene, leading to the loss of functional protein. This allows scientists to observe phenotypic changes in cellular behavior, elucidate signaling pathways, and assess the role of PRKAR2A in physiological and pathological contexts. This capability is essential for advancing our understanding of PKA-associated pathways and their implications in human health.
The scientific importance of PRKAR2A knockout cell lines stretches across diverse research and clinical applications. These models provide powerful platforms for drug discovery, enabling researchers to screen for compounds that modulate PKA activity and evaluate their therapeutic potential. Furthermore, they serve as invaluable tools in basic research, aiding in the elucidation of molecular mechanisms underlying various diseases.
What sets our PRKAR2A Gene Knockout Cell Lines apart from alternatives is our commitment to quality and reproducibility. Each line is derived from rigorously validated protocols, ensuring high specificity and efficiency of gene editing. Additionally, these cell lines are thoroughly characterized, providing detailed information on their functional and phenotypic profiles, which assists researchers in their experimental designs.
For researchers and clinicians involved in the exploration of cellular signaling pathways, these knockout cell lines represent an indispensable resource. The accurate modeling of PRKAR2A-related processes accelerates research timelines and enhances the potential for groundbreaking discoveries. Our company prides itself on expertise in the field of gene editing technologies and biological research, delivering high-quality products that foster innovation and advancing scientific inquiry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.